Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Crispr Therapeutics Ag
(NQ:
CRSP
)
55.89
+0.82 (+1.49%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 3, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
1,426,902
Open
56.70
Bid (Size)
55.95 (2)
Ask (Size)
56.18 (3)
Prev. Close
55.07
Today's Range
55.57 - 58.45
52wk Range
37.55 - 91.10
Shares Outstanding
78,935,098
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Shhh! 3 Secret Gene Editing Stocks Flying Below Wall Street’s Radar
Today 14:18 EDT
The gene editing stocks are worth tuning into as some investors out there discount their innovative, albeit early-stage pipelines.
Via
InvestorPlace
3 Growth Stocks You’ll Kick Yourself for Not Buying Today
Today 8:45 EDT
Netflix, Intuit, and Vertex Pharmaceuticals are three growth stocks to buy, each positioned for significant market share and returns.
Via
InvestorPlace
Performance
YTD
-15.40%
-15.40%
1 Month
-13.48%
-13.48%
3 Month
-13.68%
-13.68%
6 Month
+9.61%
+9.61%
1 Year
+5.21%
+5.21%
More News
Read More
3 Biotech Stocks to Buy and Hold Through 2030 and Beyond
May 02, 2024
Via
The Motley Fool
3 Gene Editing Stocks with the Potential to Make You an Overnight Millionaire
May 02, 2024
Via
InvestorPlace
Stock Market Crash Alert: 3 Must-Buy Biotech Stocks When Prices Plunge
May 01, 2024
Via
InvestorPlace
If You Invested $1000 In This Stock 5 Years Ago, You Would Have $2,000 Today
March 19, 2024
Via
Benzinga
Is It Too Late to Buy CRISPR Therapeutics Stock?
March 16, 2024
Via
The Motley Fool
Missed Out on Novo Nordisk? 2 Healthcare Stocks With Big Catalysts on the Horizon.
April 24, 2024
Via
The Motley Fool
Vertex Pharmaceuticals Just Made 2 Big Moves. Is the Stock a Buy?
April 23, 2024
Via
The Motley Fool
3 Magnificent Stocks That Could Double or More by 2030
April 13, 2024
Via
The Motley Fool
Wall Street Favorites: 3 Biotech Stocks With Strong Buy Ratings for April 2024
April 11, 2024
Via
InvestorPlace
Better Buy: CRISPR Therapeutics Vs. Viking Therapeutics
April 09, 2024
Via
The Motley Fool
Bull Market and Beyond: 3 Stocks Just Waiting to Soar
April 09, 2024
Via
The Motley Fool
Better Growth Biotech Buy: Iovance Biotherapeutics vs CRISPR Therapeutics
April 05, 2024
Via
The Motley Fool
3 Unstoppable Stocks to Buy Hand Over Fist in April
March 30, 2024
Via
The Motley Fool
Crispr Stock, A Cathie Wood Holding, Dives For The Fifth Straight Week — Here's Why
March 28, 2024
Via
Investor's Business Daily
3 Biotech Stocks That Could Be Multibaggers in the Making: March Edition
March 28, 2024
Via
InvestorPlace
3 No-Brainer Healthcare Stocks to Buy Right Now for Less Than $1,000
March 27, 2024
Via
The Motley Fool
Buying These Dirt-Cheap Stocks Could Be a Brilliant Move
March 23, 2024
Via
The Motley Fool
3 Stocks That Could Be the Next Big Thing in Gene Editing
March 21, 2024
Via
InvestorPlace
Geron Stock Doubles After Imetelstat Receives FDA Panel Approval
March 20, 2024
Via
MarketBeat
Exposures
Product Safety
The 3 Most Undervalued Cathie Wood Stocks to Buy in March 2024
March 15, 2024
Via
InvestorPlace
7 Biotech Stocks to Buy as Sector Rotation Ramps Up
March 13, 2024
Via
InvestorPlace
Cathie Wood's Ark Invest Keeps Dumping Coinbase Shares Amid Bitcoin, Crypto Buzz
March 12, 2024
Via
Benzinga
It's A Bull Market But Harder To Pick Small Cap Biotech Winners Because Of Volatility
March 11, 2024
Via
Talk Markets
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.